[1]
“Effect of Dapagliflozin in Lowering Risk of Heart Failure Severity: Meta-Analysis”, J Epidemiol Public Healt, vol. 8, no. 1, pp. 25–34, Jan. 2023, doi: 10.26911/jepublichealth.2023.08.01.03.